 The evolution of metastatic breast cancer has changed considerably in the last years with the approval of new drugs. In fact, already in 2003 Giordano et al showed that the prognosis of metastatic breast cancer patients was improved significantly from 1970s to 2000 with a median survival of 15 months in the early 1970s compared with 60 months in the last 1990s. 